Diamond Biotechnology Co., Ltd (TPEX:6815)

Diamond Biotechnology Revenue

Diamond Biotechnology had revenue of 183.89M TWD in the half year ending December 31, 2025, a decrease of -42.50%. This brings the company's revenue in the last twelve months to 464.63M, down -33.45% year-over-year. In the year 2025, Diamond Biotechnology had annual revenue of 501.49M, down -34.72%.

• Revenue (ttm): 464.63M
• Revenue Growth: -33.45%
• P/S Ratio: 2.07
• Revenue / Employee: n/a
• Employees: 45
• Market Cap: 962.85M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	501.49M	-266.76M	-34.72%
Dec 31, 2024	768.25M	152.16M	24.70%
Dec 31, 2023	616.10M	181.25M	41.68%
Dec 31, 2022	434.84M	39.64M	10.03%
Dec 31, 2021	395.20M	88.81M	28.99%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error